跳至主要内容
临床试验/NCT02335632
NCT02335632Unknown4 期

Effect of Probiotics on Gut-Liver Axis of Alcoholic Hepatitis

Chuncheon Sacred Heart Hospital0 个研究点目标入组 140 人开始时间: 2012年12月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
发起方
入组人数
140
主要终点
liver enzymes

研究概览

简要总结

Background/Aims:

The investigators explored the therapeutic effects of probiotics in patients with AH.

Methods:

Between December 2012 and January 2015, the investigators conducted a 7-day, double-controlled, randomized, prospective clinical trial comparing the efficacy of probiotics in improving liver enzymes, LPS, pro-inflammatory cytokines, stool culture, and stool Polymerase chain reaction denaturing gradient gel electrophoresis. AH was defined as an aspartate aminotransferase (AST)/alanine aminotransferase (ALT) > 2 and elevated AST (ALT) level with an alcohol consumption history within 48 hours. Patients were randomized to receive 7 days of cultured Lactobacillus rhamnosus R0011/acidophilus R0052 (120 mg/day) or placebo. The levels of liver enzymes, modified Discriminant Function (mDF), LPS, and pro-inflammatory cytokines, stool culture, and stool Polymerase chain reaction denaturing gradient gel electrophoresis were checked at baseline and again after therapy.

详细描述

Background/Aims: Alcoholic hepatitis (AH) is one of the leading causes of liver diseases. Gut-derived microbial lipopolysaccharide (LPS) has been known as a central role in the pathogenesis of AH. Some animal studies suggested an emerging role of probiotics in restoration of the bowel flora and improving liver enzymes. We explored the therapeutic effects of probiotics in patients with AH.

Methods:

Between December 2012 and January 2015, the investigators conducted a 7-day, double-controlled, randomized, prospective clinical trial comparing the efficacy of probiotics in improving liver enzymes, LPS, pro-inflammatory cytokines, stool culture, and stool Polymerase chain reaction denaturing gradient gel electrophoresis. AH was defined as an aspartate aminotransferase (AST)/alanine aminotransferase (ALT) > 2 and elevated AST (ALT) level with an alcohol consumption history within 48 hours. Patients were randomized to receive 7 days of cultured Lactobacillus rhamnosus R0011/acidophilus R0052 (120 mg/day) or placebo. The levels of liver enzymes, modified Discriminant Function (mDF), LPS, and pro-inflammatory cytokines, stool culture, and stool Polymerase chain reaction denaturing gradient gel electrophoresis were checked at baseline and again after therapy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Alcoholic hepatitis (AST/ALT >2 & elevated AST (ALT) level
  • Alcohol >60 g/day (M), >40 g/day (F) during 7 days before screening
  • Last drinks: within 48 hours prior to admission)

排除标准

  • viral hepatitis,
  • autoimmune hepatitis,
  • pancreatitis,
  • hemochromatosis,
  • Wilson's disease,
  • Drug-Induced Liver Injury,
  • infection need for antibiotics,
  • severe AH, or
  • obesity (BMI >30 kg/m2)

研究组 & 干预措施

Placebo

Placebo Comparator

For Probiotics, 7 days

干预措施: Placebo (Drug)

Probiotics

Active Comparator

Probiotics of 120 mg/day for 7days

干预措施: Probiotics (Lacidofil®) (Drug)

结局指标

主要结局

liver enzymes

时间窗: 7 days after probiotics

次要结局

  • LPS and pro-inflammatory cytokines(7 days after probiotics)
  • Stool culture and stool Polymerase chain reaction denaturing gradient gel electrophoresis(7 days after probiotics)

研究者

发起方
Chuncheon Sacred Heart Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Ki Tae Suk

Department of Internal Medicine

Chuncheon Sacred Heart Hospital

相似试验